Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-, 1mg

2-(methylthio)pyrimidine-5-carbaldehyde, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-2-yl)propanoic acid, 95.0%, 5g

Gallic acid monohydrate, min. 99%, 50 g, plastic packaging.

1,4-Dimethylquinolin-2(1H)-one, 95.0%, 5g

2-Bromo-6-iodo-3-methoxypyridine, 95.0%, 5g

1H-indazol-6-amine, 95%, 1g

Methyl 2-chlorooxazole-5-carboxylate, 95.0%, 250mg

7-BROMO-3-METHYLQUINOLINE, 95.0%, 1g

5-(Benzyloxy)-2-chloropyridine, 97%, 500mg

2-(Chloromethyl)-3,5-dioxahex-1-ene>96.0%(GC)1g

Norverapamil (hydrochloride), 5mg

BUTYL TRIFLATE, 95%, 250mg